Author Index Volume 59 (2017)
The issue number is given in front of the pagination
Aarsland, D., see Babiloni, C. (1) 339–358
Aarsland, D., see Giil, L.M. (3) 929–939
Aarsland, D., see Skogseth, R. (4) 1139–1152
Abbrescia, D.I., see Solfrizzi, V. (3) 815–849
Abhayaratna, W.P., see Shaw, M.E. (1) 113–120
Ács, P., see Darnai, G. (2) 675–681
Adegoke, O.O., F. Qiao, Y. Liu, K. Longley, S. Feng and H. Wang, Overexpression of Ubiquilin-1 Alleviates Alzheimer’s Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice (2) 575–590
Adjouadi, M., see Li, C. (4) 1269–1282
Adjouadi, M., see Loewenstein, D.A. (1) 131–139
Ae Bang, S., see Yun, C.-H. (1) 21–29
Aghaie, A., see Hajipour, M.J. (4) 1187–1202
Aghamollaii, V., see Hajipour, M.J. (4) 1187–1202
Aghaverdi, H., see Hajipour, M.J. (4) 1187–1202
Agosti, P., see Solfrizzi, V. (3) 815–849
Akaike, A., see Okuda, M. (1) 313–328
Akatsu, H., see Niwa, A. (3) 951–959
Alafuzoff, I., see Leino, M. (1) 43–56
Aldridge, G.M., see Serrano-Pozo, A. (2) 763–783
Alekhamis, Z., see Hajipour, M.J. (4) 1187–1202
Almkvist, O., see Iaccarino, L. (2) 603–614
Almqvist, E.G., see Johansson, P. (3) 1017–1026
Aloisi, M., see De Simone, M.S. (1) 241–250
Alongi, P., see Iaccarino, L. (2) 603–614
Alosco, M.L., see Tripodis, Y. (1) 251–263
Alsharif, A.A., see Shi, Y. (3) 1037–1044
Altbäcker, A., see Darnai, G. (2) 675–681
Amariglio, R.E., see Gatchel, J.R. (3) 975–985
An, Y., see Bilgel, M. (4) 1335–1347
Anand, S., J.M. Barnes, S.A. Young, D.M. Garcia, H.D. Tolley, J.S.K. Kauwe and S.W. Graves, Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer’s Disease Using Direct Infusion Mass Spectrometry (1) 277–290
Andel, R., see Markova, H. (3) 871–881
Anderson, R.M., see Lawrence, E. (4) 1359–1379
Andreadou, E., A.A. Pantazaki, M. Daniilidou and M. Tsolaki, Rhamnolipids, Microbial Virulence Factors, in Alzheimer’s Disease (1) 209–222
Andreasson, U., see Johansson, P. (3) 1017–1026
Anselmi, P., see Bussè, C. (3) 1009–1015
Anstey, K.J., see Mortby, M.E. (1) 141–153
Anstey, K.J., see Shaw, M.E. (1) 113–120
Antikainen, R., see Sindi, S. (4) 1459–1470
Antikainen, R., see Stephen, R. (2) 695–705
Arancio, O., see Manassero, G. (2) 743–751
Ard, M.C., see Bettcher, B.M. (4) 1307–1315
Arnaldi, D., see Babiloni, C. (1) 339–358
Asih, P.R., M.L. Tegg, H. Sohrabi, M. Carruthers, S.E. Gandy, F. Saad, G. Verdile, L.M. Ittner and R.N. Martins, Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer’s Disease: Testosterone as a Modifier (2) 445–466
Atyabi, F., see Hajipour, M.J. (4) 1187–1202
Au, R., see Yun, C.-H. (1) 21–29
Azhdarzadeh, M., see Hajipour, M.J. (4) 1187–1202
Babiloni, C., C. Del Percio, R. Lizio, G. Noce, S. Cordone, S. Lopez, A. Soricelli, R. Ferri, M.T. Pascarelli, F. Nobili, D. Arnaldi, F. Famà, D. Aarsland, F. Orzi, C. Buttinelli, F. Giubilei, M. Onofrj, F. Stocchi, P. Stirpe, P. Fuhr, U. Gschwandtner, G. Ransmayr, G. Caravias, H. Garn, F. Sorpresi, M. Pievani, F. D’Antonio, C. De Lena, B. Güntekin, L. Hanoğlu, E. Başar, G. Yener, D.D. Emek-Savaş, A.I. Triggiani, R. Franciotti, G.B. Frisoni, L. Bonanni and M.F. De Pandis, Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases: An EEG Study (1) 339–358
Bagattini, C., V. Mazza, L. Panizza, C. Ferrari, C. Bonomini and D. Brignani, Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer’s Disease: Future Early Diagnostic Biomarkers? (2) 643–654
Baldacci, F., see Lista, S. (4) 1327–1334
Ballard, C., see Skogseth, R. (4) 1139–1152
Bargahi, A., see Hajipour, M.J. (4) 1187–1202
Barker, W., see Li, C. (4) 1269–1282
Barnes, J.M., see Anand, S. (1) 277–290
Barnett, M., see Parsons, T.D. (4) 1227–1235
Barrett-Connor, E., see Richard, E.L. (3) 803–814
Barron, A.E., see De Lorenzi, E. (4) 1213–1226
Bartha, R., see Montero-Odasso, M. (2) 707–721
Bartolini, M., see Viticchi, G. (1) 67–75
Barulli, M.R., see Tortelli, R. (1) 121–130
Başar, E., see Babiloni, C. (1) 339–358
Bauer, R., see Loewenstein, D.A. (1) 131–139
Beare, R., see Moran, C. (2) 405–419
Becker, J.A., see Gatchel, J.R. (3) 975–985
Beishon, L., V.J. Haunton, R.B. Panerai and T.G. Robinson, Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review (1) 369–385
Bellanti, F., G. Iannelli, M. Blonda, R. Tamborra, R. Villani, A. Romano, S. Calcagnini, G. Mazzoccoli, M. Vinciguerra, S. Gaetani, A.M. Giudetti, G. Vendemiale, T. Cassano and G. Serviddio, Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease (2) 615–631
Bellomo, A., see Solfrizzi, V. (3) 815–849
Benitez, A., see Bettcher, B.M. (4) 1307–1315
Benyamin, B., see Lupton, M.K. (1) 85–99
Bereczkei, T., see Darnai, G. (2) 675–681
Berezuk, C., see Edwards, J.D. (3) 1113–1122
Bertin, H., see Cacciamani, F. (2) 753–762
Bettcher, B.M., M.C. Ard, B.R. Reed, A. Benitez, A. Simmons, E.B. Larson, J.A. Sonnen, T.J. Montine, G. Li, C.D. Keene, P.K. Crane and D. Mungas, Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study (4) 1307–1315
Bettinardi, V., see Iaccarino, L. (2) 603–614
Bharadwaj, P., N. Wijesekara, M. Liyanapathirana, P. Newsholme, L. Ittner, P. Fraser and G. Verdile, The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins (2) 421–432
Bidone, J., see Vaz, G.R. (3) 961–974
Bilgel, M., R.L. Koscik, Y. An, J.L. Prince, S.M. Resnick, S.C. Johnson and B.M. Jedynak, Temporal Order of Alzheimer’s Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies (4) 1335–1347
Billings IV, F.T., see Price, C.C. (3) 1027–1035
Bisceglia, F., see De Lorenzi, E. (4) 1213–1226
Bjerke, M., see Johansson, P. (3) 1017–1026
Black, S.E., see Edwards, J.D. (3) 1113–1122
Black, S.E., see Montero-Odasso, M. (2) 707–721
Blacker, D., see Gatchel, J.R. (3) 975–985
Blasko, I., see Defrancesco, M. (4) 1439–1448
Blennow, K., see Johansson, P. (3) 1017–1026
Blennow, K., see Lista, S. (4) 1327–1334
Blonda, M., see Bellanti, F. (2) 615–631
Bobkova, N.V., see Evgen’ev, M.B. (4) 1415–1426
Bohling, G.T., see Krasnianski, A. (1) 329–337
Bonanni, L., see Babiloni, C. (1) 339–358
Bonetto, N., see Cagnin, A. (1) 13–20
Bonomini, C., see Bagattini, C. (2) 643–654
Bopp, M.M., see Padala, K.P. (2) 565–574
Borawska, R., see Muszyński, P. (3) 903–912
Borland, E., K. Nägga, P.M. Nilsson, L. Minthon, E.D. Nilsson and S. Palmqvist, The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort (3) 893–901
Borta, A., see Küster, O.C. (3) 1097–1111
Bothwell, R., see Wilkins, H.M. (1) 291–300
Boukadida, L., see Cacciamani, F. (2) 753–762
Boulard, Y., see Mandal, P.K. (2) 537–541
Bramham, C.R., see Myrum, C. (2) 723–735
Brenner, A., see Seelye, A. (4) 1427–1437
Brignani, D., see Bagattini, C. (2) 643–654
Broersen, L.M., see Cansev, M. (1) 301–311
Bruce, D., see Moran, C. (2) 405–419
Bruce, D.G., see Sutherland, G.T. (2) 393–403
Buerger, K., see Franzmeier, N. (4) 1381–1392
Buratti, E., see Cagnin, A. (1) 13–20
Buratti, L., see Viticchi, G. (1) 67–75
Burns, J.M., see Wilkins, H.M. (1) 291–300
Burns, R., see Mortby, M.E. (1) 141–153
Bush, A.I., see Lupton, M.K. (1) 85–99
Bussè, C., P. Anselmi, S. Pompanin, G. Zorzi, F. Fragiacomo, G. Camporese, G.A. Di Bernardo, C. Semenza, P. Caffarra and A. Cagnin, Specific Verbal Memory Measures May Distinguish Alzheimer’s Disease from Dementia with Lewy Bodies (3) 1009–1015
Butenko, O., see Manassero, G. (2) 743–751
Buttinelli, C., see Babiloni, C. (1) 339–358
Caballero, M.Á.A., see Franzmeier, N. (4) 1381–1392
Cabral-Marques, O., see Giil, L.M. (3) 929–939
Cabrerizo, M., see Li, C. (4) 1269–1282
Cacciamani, F., C. Tandetnik, G. Gagliardi, H. Bertin, M.-O. Habert, H. Hampel, L. Boukadida, M. Révillon, S. Epelbaum and B. Dubois, on behalf of the INSIGHT-PreAD study group, Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer’s Disease (2) 753–762
Caffarra, P., see Bussè, C. (3) 1009–1015
Cagnin, A., S. Mariotto, M. Fiorini, M. Gaule, N. Bonetto, M. Tagliapietra, E. Buratti, G. Zanusso, S. Ferrari and S. Monaco, Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy (1) 13–20
Cagnin, A., see Bussè, C. (3) 1009–1015
Cai, H., see Wu, M. (3) 1067–1078
Calcagnini, S., see Bellanti, F. (2) 615–631
Calderón-Garcidueñas, L., see González-Maciel, A. (1) 189–208
Callahan, B.L., see Edwards, J.D. (3) 1113–1122
Callisaya M. and K. Nosaka, Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia (2) 503–513
Caltagirone, C., see De Simone, M.S. (1) 241–250
Calvani, M., see Solfrizzi, V. (3) 815–849
Calvó-Perxas, L., see Turró-Garriga, O. (3) 997–1007
Camporese, G., see Bussè, C. (3) 1009–1015
Cansev, M., M. Turkyilmaz, J.W.C. Sijben, C. Sevinc, L.M. Broersen and N. van Wijk, Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer’s Disease (1) 301–311
Cao, X., see Yu, L. (3) 913–927
Capozzo, R., see Tortelli, R. (1) 121–130
Caravias, G., see Babiloni, C. (1) 339–358
Carlesimo, G.A., see De Simone, M.S. (1) 241–250
Carruthers, M., see Asih, P.R. (2) 445–466
Casas, I., see Turró-Garriga, O. (3) 997–1007
Cassano, T., see Bellanti, F. (2) 615–631
Catak, C., see Franzmeier, N. (4) 1381–1392
Cavedo, E., see Lista, S. (4) 1327–1334
Cerami, C., see Iaccarino, L. (2) 603–614
Chaisson, C., see Tripodis, Y. (1) 251–263
Chandra, V. and V.S. Mehta, Distribution of Types of Dementia in the First 100 Patients Seen at a Dementia Clinic in India (3) 797–801
Chapman, B.P., see Lin, F.V. (1) 101–111
Chen, C., see Zhang, Z.-H. (2) 591–602
Chen, H., see Yin, Y. (3) 851–869
Chen, J., T. Zhang, S. Jiao, X. Zhou, J. Zhong, Y. Wang, J. Liu, J. Deng, S. Wang and Z. Xu, proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice (3) 941–949
Chen, K., see Ding, J. (4) 1283–1297
Chen, L., Z. Huang, Y. Du, M. Fu, H. Han, Y. Wang and Z. Dong, Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in Mice (2) 683–694
Chen, X., see Villarreal, S. (4) 1393–1413
Chen, Y., see Ding, J. (4) 1283–1297
Chen, Y., see Zhang, Z.-H. (2) 591–602
Cherbuin, N., see Shaw, M.E. (1) 113–120
Chhatwal, J., see Gatchel, J.R. (3) 975–985
Chiari, M., see De Lorenzi, E. (4) 1213–1226
Chiotis, K., see Iaccarino, L. (2) 603–614
Chung-tong Mok, V., see Wong, A. (4) 1299–1306
Chwiszczuk, L., see Skogseth, R. (4) 1139–1152
Clemens, Z., see Darnai, G. (2) 675–681
Colombo, R., see De Lorenzi, E. (4) 1213–1226
Conceicao, A., see Tarraf, W. (1) 31–42
Coppedè, F., see Stoccoro, A. (2) 559–564
Cordone, S., see Babiloni, C. (1) 339–358
Crane, P.K., see Bettcher, B.M. (4) 1307–1315
Cretich, M., see De Lorenzi, E. (4) 1213–1226
Cullell, M., see Turró-Garriga, O. (3) 997–1007
Curiel, R.E., see Loewenstein, D.A. (1) 131–139
Custodero, C., see Solfrizzi, V. (3) 815–849
D’Antonio, F., see Babiloni, C. (1) 339–358
D’Introno, A., see Solfrizzi, V. (3) 815–849
Daniele, A., see Solfrizzi, V. (3) 815–849
Daniilidou, M., see Andreadou, E. (1) 209–222
Darnai, G., S.A. Nagy, R. Horváth, P. Ács, G. Perlaki, G. Orsi, N. Kovács, A. Altbäcker, E. Plózer, D. Tényi, R. Weintraut, A. Schwarcz, F. John, E. Varga, T. Bereczkei, Z. Clemens, S. Komoly and J. Janszky, Iron Concentration in Deep Gray Matter Structures is Associated with Worse Visual Memory Performance in Healthy Young Adults (2) 675–681
Daviglus, M.L., see Tarraf, W. (1) 31–42
De Belder, M., P. Santens, A. Sieben and W. Fias, Impaired Processing of Serial Order Determines Working Memory Impairments in Alzheimer’s Disease (4) 1171–1186
De Lena, C., see Babiloni, C. (1) 339–358
De Lorenzi, E., M. Chiari, R. Colombo, M. Cretich, L. Sola, R. Vanna, P. Gagni, F. Bisceglia, C. Morasso, J.S. Lin, M. Lee, P.L. McGeer and A.E. Barron, Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly (4) 1213–1226
de Matos Simoes, R., see Kawalia, S.B. (4) 1237–1254
De Pandis, M.F., see Babiloni, C. (1) 339–358
De Simone, M.S., L. Fadda, R. Perri, M. De Tollis, M. Aloisi, C. Caltagirone and G.A. Carlesimo, Retrograde Amnesia for Episodic and Semantic Memories in Amnestic Mild Cognitive Impairment (1) 241–250
De Tollis, M., see De Simone, M.S. (1) 241–250
De Wolf, F., see Lawrence, E. (4) 1359–1379
Dechend, R., see Giil, L.M. (3) 929–939
Defrancesco, M., J. Marksteiner, G. Kemmler, W.W. Fleischhacker, I. Blasko and E.A. Deisenhammer, Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer’s Disease (4) 1439–1448
Deisenhammer, E.A., see Defrancesco, M. (4) 1439–1448
DeKosky, S., see Loewenstein, D.A. (1) 131–139
Del Percio, C., see Babiloni, C. (1) 339–358
Deng, J., see Chen, J. (3) 941–949
Dennis, R.A., see Padala, K.P. (2) 565–574
Derakhshankhah, H., see Hajipour, M.J. (4) 1187–1202
Dhananjayan, K., D. Gunawardena, N. Hearn, T. Sonntag, C. Moran, E. Gyengesi, V. Srikanth and G. Münch, Activation of Macrophages and Microglia by Interferon–γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus? (2) 467–479
Di Bernardo, G.A., see Bussè, C. (3) 1009–1015
Di Dio, C., see Tortelli, R. (1) 121–130
Dichgans, M., see Franzmeier, N. (4) 1381–1392
Dillen, K.N.H., H.I.L. Jacobs, J. Kukolja, N. Richter, B. von Reutern, Ö.A. Onur, K.-J. Langen and G.R. Fink, Functional Disintegration of the Default Mode Network in Prodromal Alzheimer’s Disease (1) 169–187
Ding, J., K. Chen, W. Zhang, M. Li, Y. Chen, Q. Yang, Y. Lv, Q. Guo and Z. Han, Topological Alterations and Symptom-Relevant Modules in the Whole-Brain Structural Network in Semantic Dementia (4) 1283–1297
Dodge, H., see Seelye, A. (4) 1427–1437
Doi, T., H. Shimada, H. Makizako, K. Tsutsumimoto, J. Verghese and T. Suzuki, Motoric Cognitive Risk Syndrome: Association with Incident Dementia and Disability (1) 77–84
Dong, Z., see Chen, L. (2) 683–694
Donovan, N.J., see Gatchel, J.R. (3) 975–985
Dora, C.L., see Vaz, G.R. (3) 961–974
dos Santos, A.M., see Lista, S. (4) 1327–1334
Dote, K., see Nagai, M. (2) 515–526
Douglas, J.T., see Yu, Q. (1) 223–239
Du, F., see Yu, Q. (1) 223–239
Du, Y., see Chen, L. (2) 683–694
Duara, R., see Li, C. (4) 1269–1282
Duara, R., see Loewenstein, D.A. (1) 131–139
Dubois, B., see Cacciamani, F. (2) 753–762
Dubois, B., see Lista, S. (4) 1327–1334
Duering, M., see Franzmeier, N. (4) 1381–1392
Dziedzic, T., see Muszyński, P. (3) 903–912
Edwards, J.D., J. Ramirez, B.L. Callahan, S.W. Tobe, P. Oh, C. Berezuk, K. Lanctôt, W. Swardfager, S. Nestor, A. Kiss, S. Strother and S.E. Black for the Alzheimer’s Disease Neuroimaging Initiative, Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study (3) 1113–1122
Emek-Savaş, D.D., see Babiloni, C. (1) 339–358
Epelbaum, S., see Cacciamani, F. (2) 753–762
Epelbaum, S., see Lista, S. (4) 1327–1334
Eramudugolla, R., see Mortby, M.E. (1) 141–153
Ersland, L., see Mandal, P.K. (2) 537–541
Ertl-Wagner, B., see Franzmeier, N. (4) 1381–1392
Eslinger, P.J., see Vasavada, M.M. (1) 359–368
Esquerda-Canals, G., J. Martí-Clúa, A.R. Roda and S. Villegas, An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer’s Disease (3) 1079–1096
Estus, S., see Vasquez, J.B. (2) 633–641
Evgen’ev, M.B., G.S. Krasnov, I.V. Nesterova, D.G. Garbuz, V.L. Karpov, A.V. Morozov, A.V. Snezhkina, A.N. Samokhin, A. Sergeev, A.M. Kulikov and N.V. Bobkova, Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer’s Disease (4) 1415–1426
Ewers, M., see Franzmeier, N. (4) 1381–1392
Fadda, L., see De Simone, M.S. (1) 241–250
Falkembach, M.C., see Vaz, G.R. (3) 961–974
Falsetti, L., see Viticchi, G. (1) 67–75
Famà, F., see Babiloni, C. (1) 339–358
Feng, S., see Adegoke, O.O. (2) 575–590
Feng, T.L., see Robillard, J.M. (1) 1–10
Ferguson, S.A., J.J. Panos, D. Sloper and V. Varma, Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer’s Disease (1) 57–66
Fernando, W.M.A.D.B., G. Somaratne, K.G. Goozee, S. Williams, H. Singh and R.N. Martins, Diabetes and Alzheimer’s Disease: Can Tea Phytochemicals Play a Role in Prevention? (2) 481–501
Ferrari, C., see Bagattini, C. (2) 643–654
Ferrari, S., see Cagnin, A. (1) 13–20
Ferreira, M.A., see Lupton, M.K. (1) 85–99
Ferrer, I., see Zafar, S. (1) 265–275
Ferri, R., see Babiloni, C. (1) 339–358
Festa, E.K., A.P. Katz, B.R. Ott, G. Tremont and W.C. Heindel, Dissociable Effects of Aging and Mild Cognitive Impairment on Bottom-Up Audiovisual Integration (1) 155–167
Ffytche, D., see Skogseth, R. (4) 1139–1152
Fias, W., see De Belder, M. (4) 1171–1186
Finger, E., see Montero-Odasso, M. (2) 707–721
Fink, G.R., see Dillen, K.N.H. (1) 169–187
Fiorini, M., see Cagnin, A. (1) 13–20
Fissler, P., see Küster, O.C. (3) 1097–1111
Flaqué, M., see Turró-Garriga, O. (3) 997–1007
Fleischhacker,W.W., see Defrancesco, M. (4) 1439–1448
Floris, R., see Lista, S. (4) 1327–1334
Fong, C.-h., see Wong, A. (4) 1299–1306
Forest, T., see Villarreal, S. (4) 1393–1413
Forlini, C., Patient Preferences May Be Indicative of Normative Issues in Dementia Research (1) 11–12
Fornage, M., see Tarraf, W. (1) 31–42
Fragiacomo, F., see Bussè, C. (3) 1009–1015
Franciotti, R., see Babiloni, C. (1) 339–358
Franzmeier, N., J.C. Hartmann, A.N.W. Taylor, M.Á.A. Caballero, L. Simon-Vermot, K. Buerger, L.M. Kambeitz-Ilankovic, B. Ertl-Wagner, C. Mueller, C. Catak, D. Janowitz, R. Stahl, M. Dichgans, M. Duering and M. Ewers, Left Frontal Hub Connectivity during Memory Performance Supports Reserve in Aging and Mild Cognitive Impairment (4) 1381–1392
Fraser, P., see Bharadwaj, P. (2) 421–432
Freedman, M., see Montero-Odasso, M. (2) 707–721
Frisoni, G.B., see Babiloni, C. (1) 339–358
Frisoni, G.B., see Iyappan, A. (4) 1153–1169
Fu, M., see Chen, L. (2) 683–694
Fuhr, P., see Babiloni, C. (1) 339–358
Fujita, Y., see Okuda, M. (1) 313–328
Fung, T.T., see Richard, E.L. (3) 803–814
Gaetani, S., see Bellanti, F. (2) 615–631
Gagliardi, G., see Cacciamani, F. (2) 753–762
Gagni, P., see De Lorenzi, E. (4) 1213–1226
Gallo, J.J., see Gross, A.L. (4) 1349–1358
Gallo, L., see Tarraf, W. (1) 31–42
Galzitskaya, O.V. and O.M. Selivanova, Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis (3) 785–795
Gandy, S.E., see Asih, P.R. (2) 445–466
Gao, J., see Yu, L. (3) 913–927
Garaci, F., see Lista, S. (4) 1327–1334
Garbuz, D.G., see Evgen’ev, M.B. (4) 1415–1426
Garcia, D.M., see Anand, S. (1) 277–290
Garn, H., see Babiloni, C. (1) 339–358
Garre-Olmo, J., see Turró-Garriga, O. (3) 997–1007
Garvan, C., see Price, C.C. (3) 1027–1035
Gatchel, J.R., N.J. Donovan, J.J. Locascio, A.P. Schultz, J.A. Becker, J. Chhatwal, K.V. Papp, R.E. Amariglio, D.M. Rentz, D. Blacker, R.A. Sperling, K.A. Johnson and G.A. Marshall, Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study (3) 975–985
Gaule, M., see Cagnin, A. (1) 13–20
Gavett, B.E., see Tripodis, Y. (1) 251–263
Ghasemi, F., see Hajipour, M.J. (4) 1187–1202
Giannelli, G., see Tortelli, R. (1) 121–130
Gianolli, L., see Iaccarino, L. (2) 603–614
Gich, J., see Turró-Garriga, O. (3) 997–1007
Giil, L.M., C.A. Vedeler, E.K. Kristoffersen, J.E. Nordrehaug, H. Heidecke, R. Dechend, K. Schulze-Forster, D.N. Muller, V.S. von Goetze, O. Cabral-Marques, G. Riemekasten, P. Vogelsang, S. Nygaard, A. Lund and D. Aarsland, Antibodies to Signaling Molecules and Receptors in Alzheimer’s Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function (3) 929–939
Gill, D.J., see Vasavada, M.M. (1) 359–368
Giubilei, F., see Babiloni, C. (1) 339–358
Giudetti, A.M., see Bellanti, F. (2) 615–631
Golde, T., see Loewenstein, D.A. (1) 131–139
González, H.M., see Tarraf, W. (1) 31–42
González-Maciel, A., R. Reynoso-Robles, R. Torres-Jardón, P.S. Mukherjee and L. Calderón-Garcidueñas, Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer’s Disease Development (1) 189–208
Goozee, K.G., see Fernando, W.M.A.D.B. (2) 481–501
Gordon, S.D., see Lupton, M.K. (1) 85–99
Govind, V., see Mandal, P.K. (2) 537–541
Grasso, A., see Tortelli, R. (1) 121–130
Graves, S.W., see Anand, S. (1) 277–290
Greco, A., see Solfrizzi, V. (3) 815–849
Greenberg, B., see Montero-Odasso, M. (2) 707–721
Greve, D.N., see Yun, C.-H. (1) 21–29
Grieg-Custo, M., see Loewenstein, D.A. (1) 131–139
Grimes, D.A., see Montero-Odasso, M. (2) 707–721
Grosche, J., see Michalski, D. (2) 655–674
Gross, A.L., H. Lu, L. Meoni, J.J. Gallo, J.A. Schrack and A.R. Sharrett, Physical Activity in Midlife is not Associated with Cognitive Health in Later Life Among Cognitively Normal Older Adults (4) 1349–1358
Gschwandtner, U., see Babiloni, C. (1) 339–358
Gu, L., see Shi, Y. (3) 1037–1044
Guerra, V., see Solfrizzi, V. (3) 815–849
Guerra, V., see Tortelli, R. (1) 121–130
Guglielmotto, M., see Manassero, G. (2) 743–751
Gunawardena, D., see Dhananjayan, K. (2) 467–479
Güntekin, B., see Babiloni, C. (1) 339–358
Guo, Q., see Ding, J. (4) 1283–1297
Gyengesi, E., see Dhananjayan, K. (2) 467–479
Haavik, J., see Myrum, C. (2) 723–735
Habert, M.-O., see Cacciamani, F. (2) 753–762
Hadjichrysanthou, C., see Lawrence, E. (4) 1359–1379
Hädrich, G., see Vaz, G.R. (3) 961–974
Hajipour, M.J., F. Ghasemi, H. Aghaverdi, M. Raoufi, U. Linne, F. Atyabi, I. Nabipour, M. Azhdarzadeh, H. Derakhshankhah, A. Lotfabadi, A. Bargahi, Z. Alekhamis, A. Aghaie, E. Hashemi, A. Tafakhori, V. Aghamollaii, M.M. Mashhadi, S. Sheibani, H. Vali and M. Mahmoudi, Sensing of Alzheimer’s Disease and Multiple Sclerosis Using Nano-Bio Interfaces (4) 1187–1202
Hampel, H., see Cacciamani, F. (2) 753–762
Hampel, H., see Lista, S. (4) 1327–1334
Han, H., see Chen, L. (2) 683–694
Han, S., see Yin, Y. (3) 851–869
Han, Z., see Ding, J. (4) 1283–1297
Hänninen, T., see Sindi, S. (4) 1459–1470
Hänninen, T., see Stephen, R. (2) 695–705
Hanoğlu, L., see Babiloni, C. (1) 339–358
Harpole, R., see Vasquez, J.B. (2) 633–641
Härtig, W., see Michalski, D. (2) 655–674
Hartmann, J.C., see Franzmeier, N. (4) 1381–1392
Hashemi, E., see Hajipour, M.J. (4) 1187–1202
Hashizume, Y., see Niwa, A. (3) 951–959
Haunton, V.J., see Beishon, L. (1) 369–385
He, Y., see Wu, M. (3) 1067–1078
Hearn, N., see Dhananjayan, K. (2) 467–479
Heath, A.C., see Lupton, M.K. (1) 85–99
Hegele, R.A., see Montero-Odasso, M. (2) 707–721
Heidecke, H., see Giil, L.M. (3) 929–939
Heindel, W.C., see Festa, E.K. (1) 155–167
Heinemann, U., see Krasnianski, A. (1) 329–337
Helisalmi, S., see Stephen, R. (2) 695–705
Hengerer, B., see Küster, O.C. (3) 1097–1111
Hernández-Ferrándiz, M., see Turró-Garriga, O. (3) 997–1007
Higashihara, T., see Nagai, M. (2) 515–526
Hijikuro, I., see Okuda, M. (1) 313–328
Hizel, L.P., see Price, C.C. (3) 1027–1035
Hodges, J.R., see Tu, S. (3) 883–892
Hofmann, S., see Michalski, D. (2) 655–674
Hofmann-Apitius, M., see Iyappan, A. (4) 1153–1169
Hofmann-Apitius, M., see Kawalia, S.B. (4) 1237–1254
Hofmann-Apitius, M., see Kodamullil, A.T. (3) 1045–1055
Holder, D., see Villarreal, S. (4) 1393–1413
Hong, H., Y. Li and B. Su, Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer’s Disease in APP/PS1 Transgenic Mouse (4) 1449–1458
Horn, A.P., see Vaz, G.R. (3) 961–974
Hornberger, M., see Tu, S. (3) 883–892
Hort, J., see Markova, H. (3) 871–881
Hort, M.A., see Vaz, G.R. (3) 961–974
Hortobágyi, T., see Skogseth, R. (4) 1139–1152
Horváth, R., see Darnai, G. (2) 675–681
Hovatta, I., see Sindi, S. (4) 1459–1470
Hu, N., see Li, D. (4) 1317–1325
Huang, Z., see Chen, L. (2) 683–694
Hudson, C., see Montero-Odasso, M. (2) 707–721
Huynh, K., R.N. Martins and P.J. Meikle, Lipidomic Profiles in Diabetes and Dementia (2) 433–444
Hyde, L.A., see Villarreal, S. (4) 1393–1413
Iaccarino, L., K. Chiotis, P. Alongi, O. Almkvist, A. Wall, C. Cerami, V. Bettinardi, L. Gianolli, A. Nordberg and D. Perani, A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer’s Disease in a Clinical Setting (2) 603–614
Iannelli, G., see Bellanti, F. (2) 615–631
Ii, Y., see Niwa, A. (3) 951–959
Imbimbo, B.P., see Solfrizzi, V. (3) 815–849
Imbimbo, B.P., see Tortelli, R. (1) 121–130
Ishikawa, H., see Niwa, A. (3) 951–959
Ismail, Z., see Mortby, M.E. (1) 141–153
Ittner, L., see Bharadwaj, P. (2) 421–432
Ittner, L.M., see Asih, P.R. (2) 445–466
Iyappan, A., E. Younesi, A. Redolfi, H. Vrooman, S. Khanna, G.B. Frisoni and M. Hofmann-Apitius, for the Alzheimer’s Disease Neuroimaging Initiative, Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features (4) 1153–1169
Iyappan, A., see Kodamullil, A.T. (3) 1045–1055
Izumi, Y., see Okuda, M. (1) 313–328
Jackson, R.L., see Wilkins, H.M. (1) 291–300
Jacobs, H.I.L., see Dillen, K.N.H. (1) 169–187
Janowitz, D., see Franzmeier, N. (4) 1381–1392
Janszky, J., see Darnai, G. (2) 675–681
Jedynak, B.M., see Bilgel, M. (4) 1335–1347
Jia, J., see Li, D. (4) 1317–1325
Jiang, J.M., E.K. Seng, M.E. Zimmerman, M. Sliwinski, M. Kim and R.B. Lipton, Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older Adults (3) 987–996
Jiao, S., see Chen, J. (3) 941–949
Johansson, J.-O., see Johansson, P. (3) 1017–1026
Johansson, P., E.G. Almqvist, M. Bjerke, A. Wallin, J.-O. Johansson, U. Andreasson, K. Blennow, H. Zetterberg and J. Svensson, Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer’s Disease (3) 1017–1026
John, F., see Darnai, G. (2) 675–681
Johnson, K.A., see Gatchel, J.R. (3) 975–985
Johnson, S.C., see Bilgel, M. (4) 1335–1347
Kagawa, E., see Nagai, M. (2) 515–526
Kai-yu Tong, R., see Wong, A. (4) 1299–1306
Kambeitz-Ilankovic, L.M., see Franzmeier, N. (4) 1381–1392
Kaplan, R.C., see Tarraf, W. (1) 31–42
Karabatsiakis, A., see Küster, O.C. (3) 1097–1111
Kåreholt, I., see Sindi, S. (4) 1459–1470
Karki, R., see Kodamullil, A.T. (3) 1045–1055
Karpov, V.L., see Evgen’ev, M.B. (4) 1415–1426
Karunanayaka, P., see Vasavada, M.M. (1) 359–368
Kato, M., see Nagai, M. (2) 515–526
Katz, A.P., see Festa, E.K. (1) 155–167
Kauwe, J.S.K., see Anand, S. (1) 277–290
Kawalia, S.B., T. Raschka, M. Naz, R. de Matos Simoes, P. Senger and M. Hofmann-Apitius, Analytical Strategy to Prioritize Alzheimer’s Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data (4) 1237–1254
Kaye, J., see Seelye, A. (4) 1427–1437
Keene, C.D., see Bettcher, B.M. (4) 1307–1315
Kemmler, G., see Defrancesco, M. (4) 1439–1448
Kemppainen, N., see Stephen, R. (2) 695–705
Kennedy, M.E., see Villarreal, S. (4) 1393–1413
Khalsa, D.S., see Sindi, S. (4) 1459–1470
Khanna, S., see Iyappan, A. (4) 1153–1169
Kilimann, I., see Lista, S. (4) 1327–1334
Kim, H., see Yun, C.-H. (1) 21–29
Kim, M., see Jiang, J.M. (3) 987–996
Kim, S.E., see Yun, C.-H. (1) 21–29
Kiss, A., see Edwards, J.D. (3) 1113–1122
Kiukaanniemi, S.K., see Stephen, R. (2) 695–705
Kivipelto, M., see Sindi, S. (4) 1459–1470
Kivipelto, M., see Stephen, R. (2) 695–705
Kleinstiver, P.W., see Montero-Odasso, M. (2) 707–721
Klimkowicz-Mrowiec, A., see Muszyński, P. (3) 903–912
Kloszewska, I., see Lupton, M.K. (1) 85–99
Kobayashi, Y., see Okuda, M. (1) 313–328
Kodamullil, A.T., A. Iyappan, R. Karki, S. Madan, E. Younesi and M. Hofmann-Apitius, Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models (3) 1045–1055
Kolassa, I.-T., see Küster, O.C. (3) 1097–1111
Komoly, S., see Darnai, G. (2) 675–681
Kopecek, M., see Markova, H. (3) 871–881
Koppel, S., see Wilkins, H.M. (1) 291–300
Koscik, R.L., see Bilgel, M. (4) 1335–1347
Kovács, N., see Darnai, G. (2) 675–681
Kowall, N., see Tripodis, Y. (1) 251–263
Krasnianski, A., G.T. Bohling, U. Heinemann, D. Varges, B. Meissner, W.J. Schulz-Schaeffer, A. Reif and I. Zerr, Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany (1) 329–337
Krasnov, G.S., see Evgen’ev, M.B. (4) 1415–1426
Kristoffersen, E.K., see Giil, L.M. (3) 929–939
Kritz-Silverstein, D., see Richard, E.L. (3) 803–814
Ku Lee, S., see Yun, C.-H. (1) 21–29
Kukolja, J., see Dillen, K.N.H. (1) 169–187
Kulczyńska-Przybik, A., see Muszyński, P. (3) 903–912
Kulikov, A.M., see Evgen’ev, M.B. (4) 1415–1426
Kume, T., see Okuda, M. (1) 313–328
Küster, O.C., D. Laptinskaya, P. Fissler, C. Schnack, M. Zügel, V. Nold, F. Thurm, S. Pleiner, A. Karabatsiakis, B. von Einem, P. Weydt, A. Liesener, A. Borta, A. Woll, B. Hengerer, I.-T. Kolassa and C.A.F. von Arnim, Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway (3) 1097–1111
La Montagna, M., see Solfrizzi, V. (3) 815–849
Laatikainen, T., see Sindi, S. (4) 1459–1470
Laatikainen, T., see Stephen, R. (2) 695–705
Lamar, M., see Tarraf, W. (1) 31–42
Lamari, F., see Lista, S. (4) 1327–1334
Lanctôt, K., see Edwards, J.D. (3) 1113–1122
Lang, A.E., see Montero-Odasso, M. (2) 707–721
Langen, K.-J., see Dillen, K.N.H. (1) 169–187
Laptinskaya, D., see Küster, O.C. (3) 1097–1111
Larson, E.B., see Bettcher, B.M. (4) 1307–1315
Laughlin, G.A., see Richard, E.L. (3) 803–814
Lawrence, E., C. Vegvari, A. Ower, C. Hadjichrysanthou, F. De Wolf and R.M. Anderson, A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers (4) 1359–1379
Lee, H.-Y., see Yun, C.-H. (1) 21–29
Lee, M., see De Lorenzi, E. (4) 1213–1226
Lehrer, S., P.H. Rheinstein and K.E. Rosenzweig, Association of Radon Background and Total Background Ionizing Radiation with Alzheimer’s Disease Deaths in U.S. States (2) 737–741
Leino, M., S.N. Popova and I. Alafuzoff, Transactive DNA Binding Protein 43 Rather Than Other Misfolded Proteins in the Brain is Associated with Islet Amyloid Polypeptide in Pancreas in Aged Subjects with Diabetes Mellitus (1) 43–56
Lensing, S.Y., see Padala, K.P. (2) 565–574
Leung, K.-t., see Wong, A. (4) 1299–1306
Levälahti, E., see Sindi, S. (4) 1459–1470
Levälahti, E., see Stephen, R. (2) 695–705
Li, C., D.A. Loewenstein, R. Duara, M. Cabrerizo, W. Barker and M. Adjouadi for the Alzheimer’s Disease Neuroimaging Initiative, The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort (4) 1269–1282
Li, C., see Loewenstein, D.A. (1) 131–139
Li, D., N. Hu, Y. Yu, A. Zhou, F. Li and J. Jia, Trajectories of Multidimensional Caregiver Burden in Chinese Informal Caregivers for Dementia: Evidence from Exploratory and Confirmatory Factor Analysis of the Zarit Burden Interview (4) 1317–1325
Li, F., see Li, D. (4) 1317–1325
Li, G., see Bettcher, B.M. (4) 1307–1315
Li, M., see Ding, J. (4) 1283–1297
Li, S., see Wang, D. (4) 1255–1267
Li, S.-J., Shi-Jiang Li, PhD, Recipient of 2017 Alzheimer Award (2) 387–388
Li, Y., see Hong, H. (4) 1449–1458
Lian, Y., L.D. Xiao, F. Zeng, X. Wu, Z. Wang and H. Ren, The Experiences of People with Dementia and Their Caregivers in Dementia Diagnosis (4) 1203–1211
Liesener, A., see Küster, O.C. (3) 1097–1111
Lim, J., see Sutherland, G.T. (2) 393–403
Lin, F.V., X. Wang, R. Wu, G.W. Rebok, B.P. Chapman and the Alzheimer’s Disease Neuroimaging Initiative, Identification of Successful Cognitive Aging in the Alzheimer’s Disease Neuroimaging Initiative Study (1) 101–111
Lin, J.S., see De Lorenzi, E. (4) 1213–1226
Linares, M., see Turró-Garriga, O. (3) 997–1007
Lindström, J., see Sindi, S. (4) 1459–1470
Linne, U., see Hajipour, M.J. (4) 1187–1202
Lipton, R.B., see Jiang, J.M. (3) 987–996
Lista, S., N. Toschi, F. Baldacci, H. Zetterberg, K. Blennow, I. Kilimann, S.J. Teipel, E. Cavedo, A.M. dos Santos, S. Epelbaum, F. Lamari, B. Dubois, R. Nisticò, R. Floris, F. Garaci, H. Hampel and for the Alzheimer Precision Medicine Initiative (APMI), Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study (4) 1327–1334
Litman-Zawadzka, A., see Muszyński, P. (3) 903–912
Liu, J., see Chen, J. (3) 941–949
Liu, Q., see Zhang, Z.-H. (2) 591–602
Liu, X., see Wang, D. (4) 1255–1267
Liu, Y., see Adegoke, O.O. (2) 575–590
Liu, Y., see Stephen, R. (2) 695–705
Liu, Y., see Wang, D. (4) 1255–1267
Liu, Y., see Yu, L. (3) 913–927
Liyanapathirana, M., see Bharadwaj, P. (2) 421–432
Lizagarra, G., see Loewenstein, D.A. (1) 131–139
Lizio, R., see Babiloni, C. (1) 339–358
Locascio, J.J., see Gatchel, J.R. (3) 975–985
Loewenstein, D.A., R.E. Curiel, S. DeKosky, M. Rosselli, R. Bauer, M. Grieg-Custo, A. Penate, C. Li, G. Lizagarra, T. Golde, M. Adjouadi and R. Duara, Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study (1) 131–139
Loewenstein, D.A., see Li, C. (4) 1269–1282
Logroscino, G., see Solfrizzi, V. (3) 815–849
Logroscino, G., see Tortelli, R. (1) 121–130
Longley, K., see Adegoke, O.O. (2) 575–590
Lopez, M.G., see Price, C.C. (3) 1027–1035
Lopez, S., see Babiloni, C. (1) 339–358
Lotfabadi, A., see Hajipour, M.J. (4) 1187–1202
Love, S., see Sinclair, L.I. (3) 1123–1137
Lovestone, S., see Lupton, M.K. (1) 85–99
Lozupone, M., see Solfrizzi, V. (3) 815–849
Lozupone, M., see Tortelli, R. (1) 121–130
Lu, H., see Gross, A.L. (4) 1349–1358
Lund, A., see Giil, L.M. (3) 929–939
Lupton, M.K., B. Benyamin, P. Proitsi, D.R. Nyholt, M.A. Ferreira, G.W. Montgomery, A.C. Heath, P.A. Madden, S.E. Medland, S.D. Gordon, GERAD1 Consortium, the Alzheimer’s Disease Neuroimaging Initiative, S. Lovestone, M. Tsolaki, I. Kloszewska, H. Soininen, P. Mecocci, B. Vellas, J.F. Powell, A.I. Bush, M.J. Wright, N.G. Martin and J.B. Whitfield, No Genetic Overlap Between Circulating Iron Levels and Alzheimer’s Disease (1) 85–99
Luzzi, S., see Viticchi, G. (1) 67–75
Lv, Y., see Ding, J. (4) 1283–1297
Machan, J.T., see Santos, C.Y. (3) 1057–1065
Madan, S., see Kodamullil, A.T. (3) 1045–1055
Madden, P.A., see Lupton, M.K. (1) 85–99
Maeda, M., see Niwa, A. (3) 951–959
Mahmoudi, M., see Hajipour, M.J. (4) 1187–1202
Mahnken, J.D., see Wilkins, H.M. (1) 291–300
Makizako, H., see Doi, T. (1) 77–84
Manassero, G., M. Guglielmotto, D. Monteleone, V. Vasciaveo, O. Butenko, E. Tamagno, O. Arancio and M. Tabaton, Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice (2) 743–751
Mandal, P.K., D. Shukla, V. Govind, Y. Boulard and L. Ersland, Glutathione Conformations and Its Implications for in vivo Magnetic Resonance Spectroscopy (2) 537–541
Mariotto, S., see Cagnin, A. (1) 13–20
Markova, H., R. Andel, H. Stepankova, M. Kopecek, T. Nikolai, J. Hort, C. Thomas-Antérion and M. Vyhnalek, Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms (3) 871–881
Marksteiner, J., see Defrancesco, M. (4) 1439–1448
Marshall, G.A., see Gatchel, J.R. (3) 975–985
Martí-Clúa, J., see Esquerda-Canals, G. (3) 1079–1096
Martin, B., see Tripodis, Y. (1) 251–263
Martin, N.G., see Lupton, M.K. (1) 85–99
Martinez, B., see Vasavada, M.M. (1) 359–368
Martins, R.N., see Asih, P.R. (2) 445–466
Martins, R.N., see Fernando, W.M.A.D.B. (2) 481–501
Martins, R.N., see Huynh, K. (2) 433–444
Martins, R.N., Understanding the Link between Dementia and Diabetes (2) 389–392
Masellis, M., see Montero-Odasso, M. (2) 707–721
Mashhadi, M.M., see Hajipour, M.J. (4) 1187–1202
Matsuo, K., see Niwa, A. (3) 951–959
Mattek, N., see Seelye, A. (4) 1427–1437
Mazza, V., see Bagattini, C. (2) 643–654
Mazzoccoli, G., see Bellanti, F. (2) 615–631
McClean, M.D., see Tripodis, Y. (1) 251–263
McEvoy, L.K., see Richard, E.L. (3) 803–814
McGeer, P.L., see De Lorenzi, E. (4) 1213–1226
McIlroy, W., see Montero-Odasso, M. (2) 707–721
McLaughlin, P.M., see Montero-Odasso, M. (2) 707–721
Mecocci, P., see Lupton, M.K. (1) 85–99
Medland, S.E., see Lupton, M.K. (1) 85–99
Mehta, V.S., see Chandra, V. (3) 797–801
Meikle, P.J., see Huynh, K. (2) 433–444
Meissner, B., see Krasnianski, A. (1) 329–337
Meoni, L., see Gross, A.L. (4) 1349–1358
Mez, J., see Tripodis, Y. (1) 251–263
Michalski, D., S. Hofmann, R. Pitsch, J. Grosche and W. Härtig, Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies (2) 655–674
Migliore, L., see Stoccoro, A. (2) 559–564
Minthon, L., see Borland, E. (3) 893–901
Misciagna, G., see Tortelli, R. (1) 121–130
Miyauchi, S., see Nagai, M. (2) 515–526
Mizrahi, R., see Moran, C. (2) 405–419
Monaco, S., see Cagnin, A. (1) 13–20
Monserrat, J.M., see Vaz, G.R. (3) 961–974
Monteleone, D., see Manassero, G. (2) 743–751
Montero-Odasso, M., F. Pieruccini-Faria, R. Bartha, S.E. Black, E. Finger, M. Freedman, B. Greenberg, D.A. Grimes, R.A. Hegele, C. Hudson, P.W. Kleinstiver, A.E. Lang, M. Masellis, P.M. McLaughlin, D.P. Munoz, S. Strother, R.H. Swartz, S. Symons, M.C. Tartaglia, L. Zinman, M.J. Strong ONDRI Investigators and W. McIlroy, Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI) (2) 707–721
Montgomery, G.W., see Lupton, M.K. (1) 85–99
Montine, T.J., see Bettcher, B.M. (4) 1307–1315
Moran, C., R. Beare, T. Phan, S. Starkstein, D. Bruce, R. Mizrahi and V. Srikanth, Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction (2) 405–419
Moran, C., see Dhananjayan, K. (2) 467–479
Morasso, C., see De Lorenzi, E. (4) 1213–1226
Morozov, A.V., see Evgen’ev, M.B. (4) 1415–1426
Mortby, M.E., R. Burns, R. Eramudugolla, Z. Ismail and K.J. Anstey, Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms (1) 141–153
Mroczko, B., see Muszyński, P. (3) 903–912
Muccillo-Baisch, A.L., see Vaz, G.R. (3) 961–974
Mueller, C., see Franzmeier, N. (4) 1381–1392
Mukherjee, P.S., see González-Maciel, A. (1) 189–208
Muller, D.N., see Giil, L.M. (3) 929–939
Münch, G., see Dhananjayan, K. (2) 467–479
Mungas, D., see Bettcher, B.M. (4) 1307–1315
Munoz, D.P., see Montero-Odasso, M. (2) 707–721
Muszyński, P., A. Kulczyńska-Przybik, R. Borawska, A. Litman-Zawadzka, A. Słowik, A. Klimkowicz-Mrowiec, J. Pera, T. Dziedzic and B. Mroczko, The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer’s Disease (3) 903–912
Myrum, C., O. Nikolaienko, C.R. Bramham, J. Haavik and T. Zayats, Implication of the APP Gene in Intellectual Abilities (2) 723–735
Nabipour, I., see Hajipour, M.J. (4) 1187–1202
Nagai, M., K. Dote, M. Kato, S. Sasaki, N. Oda, E. Kagawa, Y. Nakano, A. Yamane, T. Higashihara, S. Miyauchi and A. Tsuchiya, Visit-to-Visit Blood Pressure Variability and Alzheimer’s Disease: Links and Risks (2) 515–526
Nägga, K., see Borland, E. (3) 893–901
Nagy, S.A., see Darnai, G. (2) 675–681
Nakano, Y., see Nagai, M. (2) 515–526
Naz, M., see Kawalia, S.B. (4) 1237–1254
Nesterova, I.V., see Evgen’ev, M.B. (4) 1415–1426
Nestor, S., see Edwards, J.D. (3) 1113–1122
Newsholme, P., see Bharadwaj, P. (2) 421–432
Ngandu, T., see Sindi, S. (4) 1459–1470
Ngandu, T., see Stephen, R. (2) 695–705
Ni, J.-Z., see Zhang, Z.-H. (2) 591–602
Nikolai, T., see Markova, H. (3) 871–881
Nikolaienko, O., see Myrum, C. (2) 723–735
Nilsson, E.D., see Borland, E. (3) 893–901
Nilsson, P.M., see Borland, E. (3) 893–901
Nishimoto, T., see Okuda, M. (1) 313–328
Nisticò, R., see Lista, S. (4) 1327–1334
Niwa, A., Y. Ii, A. Shindo, K. Matsuo, H. Ishikawa, A. Taniguchi, S. Takase, M. Maeda, H. Sakuma, H. Akatsu, Y. Hashizume and H. Tomimoto, Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology (3) 951–959
Nobili, F., see Babiloni, C. (1) 339–358
Noce, G., see Babiloni, C. (1) 339–358
Nold, V., see Küster, O.C. (3) 1097–1111
Nordberg, A., see Iaccarino, L. (2) 603–614
Nordrehaug, J.E., see Giil, L.M. (3) 929–939
Nosaka, K., see Callisaya M. (2) 503–513
Nygaard, S., see Giil, L.M. (3) 929–939
Nyholt, D.R., see Lupton, M.K. (1) 85–99
Oda, N., see Nagai, M. (2) 515–526
Oh, P., see Edwards, J.D. (3) 1113–1122
Okuda, M., Y. Fujita, I. Hijikuro, M. Wada, T. Uemura, Y. Kobayashi, T. Waku, N. Tanaka, T. Nishimoto, Y. Izumi, T. Kume, A. Akaike, T. Takahashi and H. Sugimoto, PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8 (1) 313–328
Onofrj, M., see Babiloni, C. (1) 339–358
Onur, Ö.A., see Dillen, K.N.H. (1) 169–187
Orsi, G., see Darnai, G. (2) 675–681
Orzi, F., see Babiloni, C. (1) 339–358
Ott, B.R., see Festa, E.K. (1) 155–167
Ower, A., see Lawrence, E. (4) 1359–1379
Paajanen, T., see Sindi, S. (4) 1459–1470
Paajanen, T., see Stephen, R. (2) 695–705
Padala, K.P., P.R. Padala, S.Y. Lensing, R.A. Dennis, M.M. Bopp, P.K. Roberson and D.H. Sullivan, Home-Based Exercise Program Improves Balance and Fear of Falling in Community-Dwelling Older Adults with Mild Alzheimer’s Disease: A Pilot Study (2) 565–574
Padala, P.R., see Padala, K.P. (2) 565–574
Palmqvist, S., see Borland, E. (3) 893–901
Panerai, R.B., see Beishon, L. (1) 369–385
Panizza, L., see Bagattini, C. (2) 643–654
Panos, J.J., see Ferguson, S.A. (1) 57–66
Pantazaki, A.A., see Andreadou, E. (1) 209–222
Panza, F., see Solfrizzi, V. (3) 815–849
Panza, F., see Tortelli, R. (1) 121–130
Papp, K.V., see Gatchel, J.R. (3) 975–985
Parker, E.M., see Villarreal, S. (4) 1393–1413
Parkkola, R., see Stephen, R. (2) 695–705
Parsons, T.D. and M. Barnett, Validity of a Newly Developed Measure of Memory: Feasibility Study of the Virtual Environment Grocery Store (4) 1227–1235
Pascarelli, M.T., see Babiloni, C. (1) 339–358
Peltonen, M., see Sindi, S. (4) 1459–1470
Penate, A., see Loewenstein, D.A. (1) 131–139
Peng, F., see Xie, F. (2) 527–536
Pera, J., see Muszyński, P. (3) 903–912
Perani, D., see Iaccarino, L. (2) 603–614
Perkal , H., see Turró-Garriga, O. (3) 997–1007
Perlaki, G., see Darnai, G. (2) 675–681
Perri, R., see De Simone, M.S. (1) 241–250
Phan, T., see Moran, C. (2) 405–419
Pieruccini-Faria, F., see Montero-Odasso, M. (2) 707–721
Pievani, M., see Babiloni, C. (1) 339–358
Piguet, O., see Tu, S. (3) 883–892
Pitsch, R., see Michalski, D. (2) 655–674
Pleiner, S., see Küster, O.C. (3) 1097–1111
Plózer, E., see Darnai, G. (2) 675–681
Pompanin, S., see Bussè, C. (3) 1009–1015
Popova, S.N., see Leino, M. (1) 43–56
Powell, J.F., see Lupton, M.K. (1) 85–99
Price, C.C., C. Garvan, L.P. Hizel, M.G. Lopez and F.T. Billings IV, Delayed Recall and Working Memory MMSE Domains Predict Delirium following Cardiac Surgery (3) 1027–1035
Prince, J.L., see Bilgel, M. (4) 1335–1347
Proitsi, P., see Lupton, M.K. (1) 85–99
Provinciali, L., see Viticchi, G. (1) 67–75
Putaux, J.-L., see Vaz, G.R. (3) 961–974
Qi, J., see Wu, M. (3) 1067–1078
Qiao, F., see Adegoke, O.O. (2) 575–590
Qu, X., see Wu, M. (3) 1067–1078
Ramirez, J., see Edwards, J.D. (3) 1113–1122
Ransmayr, G., see Babiloni, C. (1) 339–358
Raoufi, M., see Hajipour, M.J. (4) 1187–1202
Raschka, T., see Kawalia, S.B. (4) 1237–1254
Rebok, G.W., see Lin, F.V. (1) 101–111
Redolfi, A., see Iyappan, A. (4) 1153–1169
Reed, B.R., see Bettcher, B.M. (4) 1307–1315
Reif, A., see Krasnianski, A. (1) 329–337
Ren, H., see Lian, Y. (4) 1203–1211
Rentz, D.M., see Gatchel, J.R. (3) 975–985
Resnick, S.M., see Bilgel, M. (4) 1335–1347
Révillon, M., see Cacciamani, F. (2) 753–762
Reynoso-Robles, R., see González-Maciel, A. (1) 189–208
Rheinstein, P.H., see Lehrer, S. (2) 737–741
Richard, E.L., D. Kritz-Silverstein, G.A. Laughlin, T.T. Fung, E. Barrett-Connor and L.K. McEvoy, Alcohol Intake and Cognitively Healthy Longevity in Community-Dwelling Adults: The Rancho Bernardo Study (3) 803–814
Richter, N., see Dillen, K.N.H. (1) 169–187
Riemekasten, G., see Giil, L.M. (3) 929–939
Rinne, J.O., see Stephen, R. (2) 695–705
Roberson, P.K., see Padala, K.P. (2) 565–574
Robillard, J.M. and T.L. Feng, When Patient Engagement and Research Ethics Collide: Lessons from a Dementia Forum (1) 1–10
Robinson, T.G., see Beishon, L. (1) 369–385
Roda, A.R., see Esquerda-Canals, G. (3) 1079–1096
Rodrigues, J.L., see Vaz, G.R. (3) 961–974
Rodríguez, C.J., see Tarraf, W. (1) 31–42
Romano, A., see Bellanti, F. (2) 615–631
Rongve, A., see Skogseth, R. (4) 1139–1152
Rosenzweig, K.E., see Lehrer, S. (2) 737–741
Rosselli, M., see Loewenstein, D.A. (1) 131–139
Saad, F., see Asih, P.R. (2) 445–466
Sabbá, C., see Solfrizzi, V. (3) 815–849
Sajeva, G., see Viticchi, G. (1) 67–75
Sakuma, H., see Niwa, A. (3) 951–959
Samokhin, A.N., see Evgen’ev, M.B. (4) 1415–1426
Santens, P., see De Belder, M. (4) 1171–1186
Santos, C.Y., J.T. Machan, W.-C. Wu and P.J. Snyder, Autonomic Cardiac Function in Preclinical Alzheimer’s Disease (3) 1057–1065
Sardone, R., see Solfrizzi, V. (3) 815–849
Sardone, R., see Tortelli, R. (1) 121–130
Sasaki, S., see Nagai, M. (2) 515–526
Schilardi, A., see Solfrizzi, V. (3) 815–849
Schmitz, M., see Zafar, S. (1) 265–275
Schnack, C., see Küster, O.C. (3) 1097–1111
Schneiderman, N., see Tarraf, W. (1) 31–42
Schrack, J.A., see Gross, A.L. (4) 1349–1358
Schultz, A.P., see Gatchel, J.R. (3) 975–985
Schulze-Forster, K., see Giil, L.M. (3) 929–939
Schulz-Schaeffer, W.J., see Krasnianski, A. (1) 329–337
Schwarcz, A., see Darnai, G. (2) 675–681
Seelye, A., N. Mattek, N. Sharma, P. Witter IV, A. Brenner, K. Wild, H. Dodge and J. Kaye, Passive Assessment of Routine Driving with Unobtrusive Sensors: A New Approach for Identifying and Monitoring Functional Level in Normal Aging and Mild Cognitive Impairment (4) 1427–1437
Selivanova, O.M., see Galzitskaya, O.V. (3) 785–795
Semenza, C., see Bussè, C. (3) 1009–1015
Seng, E.K., see Jiang, J.M. (3) 987–996
Senger, P., see Kawalia, S.B. (4) 1237–1254
Seo, H.S., see Yun, C.-H. (1) 21–29
Sergeev, A., see Evgen’ev, M.B. (4) 1415–1426
Seripa, D., see Solfrizzi, V. (3) 815–849
Seripa, D., see Tortelli, R. (1) 121–130
Serrano-Pozo, A., G.M. Aldridge and Q. Zhang, Four Decades of Research in Alzheimer’s Disease (1975–2014): A Bibliometric and Scientometric Analysis (2) 763–783
Serviddio, G., see Bellanti, F. (2) 615–631
Sevinc, C., see Cansev, M. (1) 301–311
Shafiq, M., see Zafar, S. (1) 265–275
Sharma, N., see Seelye, A. (4) 1427–1437
Sharrett, A.R., see Gross, A.L. (4) 1349–1358
Shaw, M.E., W.P. Abhayaratna, K.J. Anstey and N. Cherbuin, Increasing Body Mass Index at Midlife is Associated with Increased Cortical Thinning in Alzheimer’s Disease-Vulnerable Regions (1) 113–120
Sheibani, S., see Hajipour, M.J. (4) 1187–1202
Shi, H., see Wu, M. (3) 1067–1078
Shi, Y., L. Gu, A.A. Alsharif and Z. Zhang, The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer’s Disease Patients and Controls: A Systematic Review and Meta-Analysis (3) 1037–1044
Shimada, H., see Doi, T. (1) 77–84
Shin, C., see Yun, C.-H. (1) 21–29
Shindo, A., see Niwa, A. (3) 951–959
Shukla, D., see Mandal, P.K. (2) 537–541
Siciliano, G., see Stoccoro, A. (2) 559–564
Sieben, A., see De Belder, M. (4) 1171–1186
Sijben, J.W.C., see Cansev, M. (1) 301–311
Silvestrini, M., see Viticchi, G. (1) 67–75
Simmons, A., see Bettcher, B.M. (4) 1307–1315
Simon-Vermot, L., see Franzmeier, N. (4) 1381–1392
Simpson, J.F., see Vasquez, J.B. (2) 633–641
Sinclair, L.I. and S. Love, Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life (3) 1123–1137
Sindi, S., T. Ngandu, I. Hovatta, I. Kåreholt, R. Antikainen, T. Hänninen, E. Levälahti, T. Laatikainen, J. Lindström, T. Paajanen, M. Peltonen, D.S. Khalsa, B. Wolozin, T. Strandberg, J. Tuomilehto, H. Soininen, M. Kivipelto and A. Solomon for the FINGER study group, Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial (4) 1459–1470
Singh, H., see Fernando, W.M.A.D.B. (2) 481–501
Skogseth, R., T. Hortobágyi, H. Soennesyn, L. Chwiszczuk, D. Ffytche, A. Rongve, C. Ballard and D. Aarsland, Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology (4) 1139–1152
Sliwinski, M., see Jiang, J.M. (3) 987–996
Sloper, D., see Ferguson, S.A. (1) 57–66
Słowik, A., see Muszyński, P. (3) 903–912
Snezhkina, A.V., see Evgen’ev, M.B. (4) 1415–1426
Snyder, P.J., see Santos, C.Y. (3) 1057–1065
Soennesyn, H., see Skogseth, R. (4) 1139–1152
Sohrabi, H., see Asih, P.R. (2) 445–466
Soininen, H., see Lupton, M.K. (1) 85–99
Soininen, H., see Sindi, S. (4) 1459–1470
Soininen, H., see Stephen, R. (2) 695–705
Sola, L., see De Lorenzi, E. (4) 1213–1226
Solfrizzi, V., C. Custodero, M. Lozupone, B.P. Imbimbo, V. Valiani, P. Agosti, A. Schilardi, A. D’Introno, M. La Montagna, M. Calvani, V. Guerra, R. Sardone, D.I. Abbrescia, A. Bellomo, A. Greco, A. Daniele, D. Seripa, G. Logroscino, C. Sabbá and F. Panza, Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review (3) 815–849
Solomon, A., see Sindi, S. (4) 1459–1470
Solomon, A., see Stephen, R. (2) 695–705
Somaratne, G., see Fernando, W.M.A.D.B. (2) 481–501
Sondey, M., see Villarreal, S. (4) 1393–1413
Song, G.-L., see Zhang, Z.-H. (2) 591–602
Sonnen, J.A., see Bettcher, B.M. (4) 1307–1315
Sonntag, T., see Dhananjayan, K. (2) 467–479
Soricelli, A., see Babiloni, C. (1) 339–358
Sorpresi, F., see Babiloni, C. (1) 339–358
Sperling, R.A., see Gatchel, J.R. (3) 975–985
Spiers, H.J., see Tu, S. (3) 883–892
Srikanth, V., see Dhananjayan, K. (2) 467–479
Srikanth, V., see Moran, C. (2) 405–419
Srikanth, V., see Sutherland, G.T. (2) 393–403
Stahl, R., see Franzmeier, N. (4) 1381–1392
Starkstein, S., see Moran, C. (2) 405–419
Stepankova, H., see Markova, H. (3) 871–881
Stephen, R., Y. Liu, T. Ngandu, J.O. Rinne, N. Kemppainen, R. Parkkola, T. Laatikainen, T. Paajanen, T. Hänninen, T. Strandberg, R. Antikainen, J. Tuomilehto, S.K. Kiukaanniemi, R. Vanninen, S. Helisalmi, E. Levälahti, M. Kivipelto, H. Soininen and A. Solomon, Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition (2) 695–705
Stern, R.A., see Tripodis, Y. (1) 251–263
Stirpe, P., see Babiloni, C. (1) 339–358
Stocchi, F., see Babiloni, C. (1) 339–358
Stoccoro, A., G. Siciliano, L. Migliore and F. Coppedè, Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer’s Disease (2) 559–564
Strandberg, T., see Sindi, S. (4) 1459–1470
Strandberg, T., see Stephen, R. (2) 695–705
Strong , M.J., see Montero-Odasso, M. (2) 707–721
Strother, S., see Edwards, J.D. (3) 1113–1122
Strother, S., see Montero-Odasso, M. (2) 707–721
Su, B., see Hong, H. (4) 1449–1458
Sugimoto, H., see Okuda, M. (1) 313–328
Sullivan, D.H., see Padala, K.P. (2) 565–574
Sun, X., see Vasavada, M.M. (1) 359–368
Sur, C., see Villarreal, S. (4) 1393–1413
Sutherland, G.T., J. Lim, V. Srikanth and D.G. Bruce, Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia (2) 393–403
Suzuki, T., see Doi, T. (1) 77–84
Svensson, J., see Johansson, P. (3) 1017–1026
Swardfager, W., see Edwards, J.D. (3) 1113–1122
Swartz, R.H., see Montero-Odasso, M. (2) 707–721
Swerdlow, R.H., see Wilkins, H.M. (1) 291–300
Symons, S., see Montero-Odasso, M. (2) 707–721
Tabaton, M., see Manassero, G. (2) 743–751
Tafakhori, A., see Hajipour, M.J. (4) 1187–1202
Tagliapietra, M., see Cagnin, A. (1) 13–20
Takahashi, T., see Okuda, M. (1) 313–328
Takase, S., see Niwa, A. (3) 951–959
Talavera, G.A., see Tarraf, W. (1) 31–42
Tamagno, E., see Manassero, G. (2) 743–751
Tamborra, R., see Bellanti, F. (2) 615–631
Tanaka, N., see Okuda, M. (1) 313–328
Tandetnik, C., see Cacciamani, F. (2) 753–762
Taniguchi, A., see Niwa, A. (3) 951–959
Tarraf, W., C.J. Rodríguez, M.L. Daviglus, M. Lamar, N. Schneiderman, L. Gallo, G.A. Talavera, R.C. Kaplan, M. Fornage, A. Conceicao and H.M. González, Blood Pressure and Hispanic/Latino Cognitive Function: Hispanic Community Health Study/Study of Latinos Results (1) 31–42
Tartaglia, M.C., see Montero-Odasso, M. (2) 707–721
Taylor, A.N.W., see Franzmeier, N. (4) 1381–1392
Tegg, M.L., see Asih, P.R. (2) 445–466
Teipel, S.J., see Lista, S. (4) 1327–1334
Teixeira, H.F., see Vaz, G.R. (3) 961–974
Tényi, D., see Darnai, G. (2) 675–681
Thomas, R.J., see Yun, C.-H. (1) 21–29
Thomas-Antérion, C., see Markova, H. (3) 871–881
Thurm, F., see Küster, O.C. (3) 1097–1111
Tobe, S.W., see Edwards, J.D. (3) 1113–1122
Tolley, H.D., see Anand, S. (1) 277–290
Tomimoto, H., see Niwa, A. (3) 951–959
Torres-Jardón, R., see González-Maciel, A. (1) 189–208
Tortelli, R., M. Lozupone, V. Guerra, M.R. Barulli, B.P. Imbimbo, R. Capozzo, A. Grasso, M. Tursi, C. Di Dio, R. Sardone, G. Giannelli, D. Seripa, G. Misciagna, F. Panza and G. Logroscino, Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline (1) 121–130
Toschi, N., see Lista, S. (4) 1327–1334
Tremont, G., see Festa, E.K. (1) 155–167
Triggiani, A.I., see Babiloni, C. (1) 339–358
Tripodis, Y., M.L. Alosco, N. Zirogiannis, B.E. Gavett, C. Chaisson, B. Martin, M.D. McClean, J. Mez, N. Kowall and R.A. Stern, The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer’s Disease Dementia (1) 251–263
Trumbore, C.N., Shear-Induced Amyloid Formation in the Brain: II. An Experimental System for Monitoring Amyloid Shear Processes and Investigating Potential Spinal Tap Problems (2) 543–557
Tsolaki, M., see Andreadou, E. (1) 209–222
Tsolaki, M., see Lupton, M.K. (1) 85–99
Tsuchiya, A., see Nagai, M. (2) 515–526
Tsutsumimoto, K., see Doi, T. (1) 77–84
Tu, S., H.J. Spiers, J.R. Hodges, O. Piguet and M. Hornberger, Egocentric versus Allocentric Spatial Memory in Behavioral Variant Frontotemporal Dementia and Alzheimer’s Disease (3) 883–892
Tuomilehto, J., see Sindi, S. (4) 1459–1470
Tuomilehto, J., see Stephen, R. (2) 695–705
Turkyilmaz, M., see Cansev, M. (1) 301–311
Turró-Garriga, O., L. Calvó-Perxas, J. Vilalta-Franch, M. Hernández-Ferrándiz, M. Flaqué, M. Linares, M. Cullell, J. Gich, I. Casas, H. Perkal and J. Garre-Olmo, on behalf of the Registry of Dementia of Girona Study Group (ReDeGi Study Group), Adherence to Clinical Practice Guidelines during Dementia Work-Up in a Real-World Setting: A Study from the Registry of Dementias of Girona (3) 997–1007
Tursi, M., see Tortelli, R. (1) 121–130
Uemura, T., see Okuda, M. (1) 313–328
Vali, H., see Hajipour, M.J. (4) 1187–1202
Valiani, V., see Solfrizzi, V. (3) 815–849
van Wijk, N., see Cansev, M. (1) 301–311
Vanna, R., see De Lorenzi, E. (4) 1213–1226
Vanninen, R., see Stephen, R. (2) 695–705
Varela Junior, A.S., see Vaz, G.R. (3) 961–974
Varga, E., see Darnai, G. (2) 675–681
Varges, D., see Krasnianski, A. (1) 329–337
Varma, V., see Ferguson, S.A. (1) 57–66
Vasavada, M.M., B. Martinez, J. Wang, P.J. Eslinger, D.J. Gill, X. Sun, P. Karunanayaka and Q.X. Yang, Central Olfactory Dysfunction in Alzheimer’s Disease and Mild Cognitive Impairment: A Functional MRI Study (1) 359–368
Vasciaveo, V., see Manassero, G. (2) 743–751
Vasquez, J.B., J.F. Simpson, R. Harpole and S. Estus, Alzheimer’s Disease Genetics and ABCA7 Splicing (2) 633–641
Vaz, G.R., G. Hädrich, J. Bidone, J.L. Rodrigues, M.C. Falkembach, J.-L. Putaux, M.A. Hort, J.M. Monserrat, A.S. Varela Junior, H.F. Teixeira, A.L. Muccillo-Baisch, A.P. Horn and C.L. Dora, Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting (3) 961–974
Vedeler, C.A., see Giil, L.M. (3) 929–939
Vegvari, C., see Lawrence, E. (4) 1359–1379
Vellas, B., see Lupton, M.K. (1) 85–99
Vendemiale, G., see Bellanti, F. (2) 615–631
Verdile, G., see Asih, P.R. (2) 445–466
Verdile, G., see Bharadwaj, P. (2) 421–432
Verghese, J., see Doi, T. (1) 77–84
Vilalta-Franch, J., see Turró-Garriga, O. (3) 997–1007
Villani, R., see Bellanti, F. (2) 615–631
Villarreal, S., F. Zhao, L.A. Hyde, D. Holder, T. Forest, M. Sondey, X. Chen, C. Sur, E.M. Parker and M.E. Kennedy, Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage (4) 1393–1413
Villegas, S., see Esquerda-Canals, G. (3) 1079–1096
Vinciguerra, M., see Bellanti, F. (2) 615–631
Viticchi, G., L. Falsetti, L. Buratti, G. Sajeva, S. Luzzi, M. Bartolini, L. Provinciali and M. Silvestrini, Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia (1) 67–75
Vogelsang, P., see Giil, L.M. (3) 929–939
von Arnim, C.A.F., see Küster, O.C. (3) 1097–1111
von Einem, B., see Küster, O.C. (3) 1097–1111
von Goetze, V.S., see Giil, L.M. (3) 929–939
von Reutern, B., see Dillen, K.N.H. (1) 169–187
Vrooman, H., see Iyappan, A. (4) 1153–1169
Vyhnalek, M., see Markova, H. (3) 871–881
Wada, M., see Okuda, M. (1) 313–328
Waku, T., see Okuda, M. (1) 313–328
Wall, A., see Iaccarino, L. (2) 603–614
Wallin, A., see Johansson, P. (3) 1017–1026
Wang, C., see Wang, D. (4) 1255–1267
Wang, D., X. Liu, Y. Liu, S. Li and C. Wang, The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice (4) 1255–1267
Wang, H., see Adegoke, O.O. (2) 575–590
Wang, J., see Vasavada, M.M. (1) 359–368
Wang, S., see Chen, J. (3) 941–949
Wang, X., see Lin, F.V. (1) 101–111
Wang, X., see Yin, Y. (3) 851–869
Wang, Y., see Chen, J. (3) 941–949
Wang, Y., see Chen, L. (2) 683–694
Wang, Z., see Lian, Y. (4) 1203–1211
Wang, Z., see Wu, M. (3) 1067–1078
Weintraut, R., see Darnai, G. (2) 675–681
Welch, P., see Wilkins, H.M. (1) 291–300
Weydt, P., see Küster, O.C. (3) 1097–1111
Whitfield, J.B., see Lupton, M.K. (1) 85–99
Wijesekara, N., see Bharadwaj, P. (2) 421–432
Wild, K., see Seelye, A. (4) 1427–1437
Wilkins, H.M., J.D. Mahnken, P. Welch, R. Bothwell, S. Koppel, R.L. Jackson, J.M. Burns and R.H. Swerdlow, A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer’s Disease Subjects: Results of a Single-Arm, Pilot Trial (1) 291–300
Williams, S., see Fernando, W.M.A.D.B. (2) 481–501
Witter IV, P., see Seelye, A. (4) 1427–1437
Woll, A., see Küster, O.C. (3) 1097–1111
Wolozin, B., see Sindi, S. (4) 1459–1470
Wong, A., C.-h. Fong, V. Chung-tong Mok, K.-t. Leung and R. Kai-yu Tong, Computerized Cognitive Screen (CoCoSc): A Self-Administered Computerized Test for Screening for Cognitive Impairment in Community Social Centers (4) 1299–1306
Wright, M.J., see Lupton, M.K. (1) 85–99
Wu, M., H. Shi, Y. He, L. Yuan, X. Qu, J. Zhang, Z. Wang, H. Cai and J. Qi, Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice (3) 1067–1078
Wu, Q.-Y., see Zhang, Z.-H. (2) 591–602
Wu, R., see Lin, F.V. (1) 101–111
Wu, W.-C., see Santos, C.Y. (3) 1057–1065
Wu, X., see Lian, Y. (4) 1203–1211
Xiao, L.D., see Lian, Y. (4) 1203–1211
Xie, F. and F. Peng, Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer’s Disease with Positron Emission Tomography (2) 527–536
Xu, Y., see Yu, L. (3) 913–927
Xu, Z., see Chen, J. (3) 941–949
Yamane, A., see Nagai, M. (2) 515–526
Yan, S.F., see Yu, Q. (1) 223–239
Yan, S.S., see Yu, Q. (1) 223–239
Yang, H., see Yu, L. (3) 913–927
Yang, Q., see Ding, J. (4) 1283–1297
Yang, Q.X., see Vasavada, M.M. (1) 359–368
Yener, G., see Babiloni, C. (1) 339–358
Yin, Y., Y. Zhao, S. Han, N. Zhang, H. Chen and X. Wang, Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure (3) 851–869
Younas, N., see Zafar, S. (1) 265–275
Younesi, E., see Iyappan, A. (4) 1153–1169
Younesi, E., see Kodamullil, A.T. (3) 1045–1055
Young, S.A., see Anand, S. (1) 277–290
Yu, H., see Yu, Q. (1) 223–239
Yu, L., Y. Liu, H. Yang, X. Zhu, X. Cao, J. Gao, H. Zhao and Y. Xu, PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β (3) 913–927
Yu, Q., F. Du, J.T. Douglas, H. Yu, S.S. Yan and S.F. Yan, Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer’s Disease Trans-Mitochondrial Cybrid Cells (1) 223–239
Yu, Y., see Li, D. (4) 1317–1325
Yuan, L., see Wu, M. (3) 1067–1078
Yun, C.-H., H.-Y. Lee, S. Ku Lee, H. Kim, H.S. Seo, S. Ae Bang, S.E. Kim, D.N. Greve, R. Au, C. Shin and R.J. Thomas, Amyloid Burden in Obstructive Sleep Apnea (1) 21–29
Zafar, S., M. Shafiq, N. Younas, M. Schmitz, I. Ferrer and I. Zerr, Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer’s Disease (1) 265–275
Zanusso, G., see Cagnin, A. (1) 13–20
Zayats, T., see Myrum, C. (2) 723–735
Zeng, F., see Lian, Y. (4) 1203–1211
Zerr, I., see Krasnianski, A. (1) 329–337
Zerr, I., see Zafar, S. (1) 265–275
Zetterberg, H., see Johansson, P. (3) 1017–1026
Zetterberg, H., see Lista, S. (4) 1327–1334
Zhang, J., see Wu, M. (3) 1067–1078
Zhang, N., see Yin, Y. (3) 851–869
Zhang, Q., see Serrano-Pozo, A. (2) 763–783
Zhang, T., see Chen, J. (3) 941–949
Zhang, W., see Ding, J. (4) 1283–1297
Zhang, Z., see Shi, Y. (3) 1037–1044
Zhang, Z.-H., Q.-Y. Wu, C. Chen, R. Zheng, Y. Chen, Q. Liu, J.-Z. Ni and G.-L. Song, Selenomethionine Attenuates the Amyloid-β Level by Both Inhibiting Amyloid-β Production and Modulating Autophagy in Neuron-2a/AβPPswe Cells (2) 591–602
Zhao, F., see Villarreal, S. (4) 1393–1413
Zhao, H., see Yu, L. (3) 913–927
Zhao, Y., see Yin, Y. (3) 851–869
Zheng, R., see Zhang, Z.-H. (2) 591–602
Zhong, J., see Chen, J. (3) 941–949
Zhou, A., see Li, D. (4) 1317–1325
Zhou, X., see Chen, J. (3) 941–949
Zhu, X., see Yu, L. (3) 913–927
Zimmerman, M.E., see Jiang, J.M. (3) 987–996
Zinman, L., see Montero-Odasso, M. (2) 707–721
Zirogiannis, N., see Tripodis, Y. (1) 251–263
Zorzi, G., see Bussè, C. (3) 1009–1015
Zügel, M., see Küster, O.C. (3) 1097–1111
